|
|
Quest Diagnostics Inc (DGX) |
|
|
|
| |
DGX's Revenue Growth by Quarter and Year
Quest Diagnostics Inc's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| DGX Revenue (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
| IV Quarter |
December |
-
|
2,333.00
|
2,744.00
|
3,002.00
|
| III Quarter |
September |
-
|
2,486.00
|
2,774.00
|
2,786.00
|
| II Quarter |
June |
2,338.00
|
2,453.00
|
2,550.00
|
1,827.00
|
| I Quarter |
March |
2,331.00
|
2,611.00
|
2,720.00
|
1,822.00
|
| FY |
|
4,669.00
|
9,883.00
|
10,788.00
|
9,437.00
|
| DGX Revenue second quarter 2023 Y/Y Growth Comment |
Quest Diagnostics Inc reported decrease in Revenue in the second quarter 2023 by -4.69% to $ 2,338.00 millions, from the same quarter in 2022.
The decrease in the second quarter 2023 Quest Diagnostics Inc's Revenue compares unfavorably to the Company's average Revenue growth of 4.09%.
Looking into second quarter 2023 results within Medical Laboratories industry 6 other companies have achieved higher Revenue growth. While Quest Diagnostics Inc' s Revenue decline of -4.69% ranks overall at the positon no. 1022 in the second quarter 2023.
|
| DGX Revenue ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
-14.98 % |
-8.59 % |
55.87 % |
| III Quarter |
September |
- |
-10.38 % |
-0.43 % |
42.43 % |
| II Quarter |
June |
-4.69 % |
-3.8 % |
39.57 % |
-6.45 % |
| I Quarter |
March |
-10.72 % |
-4.01 % |
49.29 % |
-3.65 % |
| FY |
|
- |
-8.39 % |
14.32 % |
22.15 % |
DGX Revenue (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
-6.15 % |
-1.08 % |
7.75 % |
| III Quarter |
September |
- |
1.35 % |
8.78 % |
52.49 % |
| II Quarter |
June |
0.3 % |
-6.05 % |
-6.25 % |
0.27 % |
| I Quarter |
March |
-0.09 % |
-4.85 % |
-9.39 % |
-5.4 % |
| FY (Year on Year) |
|
- |
-8.39 % |
14.32 % |
22.15 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 46.83 % |
4.09 % |
-10.34 % |
| (Jun 30 2021) |
|
(Jun 30 2023) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 46.83 % |
4.09 % |
-10.34 % |
| (Jun 30 2021) |
|
(Jun 30 2023) |
|
| Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Quest Diagnostics Inc's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 52.49 % |
1.05 % |
-9.39 % |
| (Sep 30 2020) |
|
|
| DGX's II. Quarter Q/Q Revenue Comment |
Quest Diagnostics Inc achieved in the II. Quarter 2023 below company average Revenue growth of 0.3% quarter on quarter, to $ 2,338.00 millions.
II. Quarter 2023 DGX's performance seem to be paradoxical, even if below the average growth of 1.05 %, yet it presents absolute recovery compare to the -6.05% in the same quarter a year ago
Within Medical Laboratories industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Quest Diagnostics Inc's Revenue growth quarter on quarter, overall rank is 857. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 52.49 % |
1.05 % |
-9.39 % |
| (Sep 30 2020) |
|
|
| DGX's II. Quarter Q/Q Revenue Comment |
Quest Diagnostics Inc achieved in the II. Quarter 2023 below company average Revenue growth of 0.3% quarter on quarter, to $ 2,338.00 millions.
Although the II. Quarter 2023 DGX's Revenue sequential growth was beneath the ordinary , it was yet encouraging story, as the II. Quarter improvement, outshines the -6.05% rise in the same quarter a year ago
Within Medical Laboratories industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Quest Diagnostics Inc's Revenue growth quarter on quarter, overall rank is 857. |
|
Quest Diagnostics Inc's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Jun 30 2023) |
12 Months Ending
(Mar 31 2023) |
12 Months Ending
(Dec 31 2022) |
12 Months Ending
(Sep 30 2022) |
12 Months Ending
(Jun 30 2022) |
| Cumulative Revenue 12 Months Ending |
$ 9,488.00 |
$ 9,603.00 |
$ 9,883.00 |
$ 10,294.00 |
$ 10,582.00 |
| Y / Y Revenue Growth (TTM) |
-10.34 % |
-10.08 % |
-8.39 % |
-6.81 % |
-4.3 % |
| Year on Year Revenue Growth Overall
Ranking |
# 1095 |
# 349 |
# 1007 |
# 2148 |
# 125 |
| Seqeuential Revenue Change (TTM) |
-1.2 % |
-2.83 % |
-3.99 % |
-2.72 % |
-0.91 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 1022 |
# 409 |
# 1933 |
# 119 |
# 1829 |
| Cumulative Revenue growth
Comment |
Quest Diagnostics Inc's cumulative 12 months Revenue continue to decline, but on the faster rate at -10.34% year on year, at Jun 30 2023 compare to the -10.08% decrease at Mar 31 2023. If the Quest Diagnostics Inc's fiscal year would end at Jun 30 2023, annual Revenue would be $9,488 millions.
In the Healthcare sector 120 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 349 to 1095. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
46.83 % |
4.09 % |
-10.34 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
46.83 % |
4.09 % |
-10.34 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 7 |
| Sector |
# 113 |
| S&P 500 |
# 1022 |
|
| Cumulative Revenue growth
Comment |
Quest Diagnostics Inc's cumulative 12 months Revenue continue to decline, but on the faster rate at -10.34% year on year, at Jun 30 2023 compare to the -10.08% decrease at Mar 31 2023. If the Quest Diagnostics Inc's fiscal year would end at Jun 30 2023, annual Revenue would be $9,488 millions.
In the Healthcare sector 120 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 349 to 1095. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
46.83 % |
4.09 % |
-10.34 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
46.83 % |
4.09 % |
-10.34 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 7 |
| Sector |
# 113 |
| S&P 500 |
# 1022 |
|
